CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma
Clinical trial NCT03881761 · UNKNOWN
Trial details
- NCT number
- NCT03881761
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2021-01-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.